April 20, 2018
Hikma’s USA subsidiary launches Zinecard generic, Dexrazoxane, for breast cancer
Hikma Pharmaceuticals has launched Dexrazoxane for Injection, 250mg and 500mg vials, the generic equivalent to Zinecard, through its US wholly-owned subsidiary…